MARTELL RON 4
4 · Jasper Therapeutics, Inc. · Filed Jun 6, 2025
Insider Transaction Report
Form 4
MARTELL RON
DirectorPresident, CEO and Director
Transactions
- Award
Stock Option (right to buy)
2025-06-04+234,000→ 234,000 totalExercise: $6.00Exp: 2035-06-04→ Voting Common Stock (234,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the retention option shall vest on June 4, 2026 and 1/48th of the shares subject to the retention option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.